Pregabalin — Drug Intelligence | 12 EU Trials

Filter these 12 trials by condition, phase, country and more.

Open in Search →

12 Registered trials

7 Recruiting

2 Completed trials

12 Sponsors

11 Countries

Phase III

Phase II

Phase IV

Phase III: 3 Phase II/III: 1 Phase II: 4 Phase IV: 3 Other: 1

Indications tested

Schizoaffective disorder 1 Schizophreniform disorder 1 Schizophrenia 1

Sponsors using this IMP

Amsterdam UMC 1 Fakultni Nemocnice V Motole 1 Fundacion Para La Gestion De La Investigacion En Salud De Sevilla 1 HUS-Yhtymae 1 Institut Jules Bordet 1 Janssen - Cilag International 1 Laboratorios Normon S.A. 1 Les Hopitaux Universitaires De Strasbourg 1 Narodowy Instytut Geriatrii Reumatologii I Rehabilitacji Im Prof. Dr Hab. Med. Eleonory Reicher 1 Region Hovedstadens Psykiatriske 1 Universitair Medisch Centrum Utrecht 1 Vertex Pharmaceuticals Inc. 1

All trials

12 total

A prospective, randomized, and controlled study comparing two treatment strategies (Dose REduction of Antipsychotics vs. Maintenance treatme… Pending

2023-509558-80-00 Phase III 1 country Les Hopitaux Universitaires De Strasbourg
Sleep structure in neuropathic pain patients, psychological factors, brain connectivity, and the effect of pregabalin on sleep and pain Pending

2024-515820-35-02 Phase IV 1 country HUS-Yhtymae
Pregabalin or Baclofen in Spastic Motor Behavior Treatment After SCI (PoBSCI), Prospective, Double-Blind, Randomised Drug Study Pending

2024-518824-56-00 Phase III 1 country Fakultni Nemocnice V Motole
Clinical trial to study the effect of an already authorized drug on other pathologies by administering it to people with a recent diagnosis … Recruiting

2024-519778-38-00 Phase II/III 1 country Fundacion Para La Gestion De La Investigacion En Salud De Sevilla
A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for schizophrenia compared to t… Recruiting

2023-506602-39-00 Phase IV 4 countries Universitair Medisch Centrum Utrecht
ADAPT: Treatment of Agitated behaviour in patients with Dementia non-responsive to guideline recommended interventions by Argued Personalise… Recruiting

2024-510601-29-00 Phase IV 1 country Amsterdam UMC
A Phase 2, Open-label, Randomized Study to Evaluate Prophylactic Interventions on Talquetamab-related Oral Toxicity Recruiting

2023-506260-14-00 Phase II 2 countries Janssen - Cilag International
Unravelling the local and systemic effects of primary surgery and perioperative use of ketorolac and pregabalin in primary breast cancer pat… Recruiting

2023-507440-36-00 Phase II 1 country Institut Jules Bordet
Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy Recruiting

2024-514689-38-01 Phase II 3 countries Vertex Pharmaceuticals Inc.
The DEXA-PSYCH Study: Dexamethasone Repurposing for Moderate to Severe Depression - A Double-Blind, Randomized, Parallel-Group, Placebo-Cont… Recruiting

2022-501428-45-00 Phase III 1 country Region Hovedstadens Psykiatriske
Investigation of treating chronic fatigue syndrome after COVID with pharmacotherapy (pregabalin) or complex rehabilitation Ended

2024-516174-30-01 Phase II 1 country Narodowy Instytut Geriatrii Reumatologii I Rehabilitacji Im Prof. Dr Hab. Med. E…
Bioequivalence clinical trial of two formulations of Pregabalin 300 mg. Ended

2022-501160-18-00 1 country Laboratorios Normon S.A.

Showing 1–12 of 12 trials

← All drugs A–Z